ESC 365 - Galectin-3 levels at presentation and left ventricular ejection fraction (LVEF) prediction in patients with STEMI/NSTEMI acute myocardial infarction. An observational study.

HFA Premium Access

Galectin-3 levels at presentation and left ventricular ejection fraction (LVEF) prediction in patients with STEMI/NSTEMI acute myocardial infarction. An observational study.

Session: Poster Session 2 - Biomarkers

Topic: Prognosis (using biomarkers)

Speaker: Doctor B. Lo Sasso (Palermo, IT)

Event: Heart Failure 2017 - 4th World Congress on Acute Heart Failure

Congress Presentation

Add to my library

About the speaker

Doctor Bruna Lo Sasso

Palermo (Italy)

0 follower

24 more presentations in this session

The value of NT-proBNP in the diagnosis of cardiac disease in patients with alcoholic liver cirrhosis

Speaker: Associate Professor P. Lazarev (Moscow, RU)

Not changes in heart failure therapy but patient characteristics at admission predict unsuccessful guidance of therapy to a target of more than 30% NT-proBNP reduction

Speaker: Miss S. Stienen (Amsterdam, NL)

Sacubitril/valsartan prevents the acute increase of n-terminal brain natriuretic peptide induced by exercise training in subjects with heart failure

The diagnostic and economic implications of using a plasma nt-probnp of 300 or 400ng/litre as the threshold for ruling out the diagnosis of heart failure in a non selected british population

Speaker: Doctor J. Webb (London, GB)

Natriuretic peptides for detection of heart failure in patients with atrial fibrillation from the community

Speaker: Professor F. Rutten (Utrecht, NL)

Access the full session

Poster Session 2 - Biomarkers

Speakers: Doctor B. Lo Sasso, Associate Professor P. Lazarev, Miss S. Stienen, Doctor J. Webb, Professor F. Rutten

About the event

Heart Failure 2017 - 4th World Congress on Acute Heart Failure

29 April - 2 May 2017

Sessions Presentations

Congress

ESC 365 is supported by

Explore sponsored resources

Explore sponsored resources